Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
THA Innovative Solutions, also referred to as THA Center for Innovative Solutions (TCIS), is a healthcare-focused business subsidiary of the Tennessee Hospital Association that connects Tennessee hospitals with vetted vendor partners. Rather than operating as a drug developer or traditional biotech company, it evaluates and endorses operational, financial, workforce, analytics, and patient-care solutions for member hospitals. The organization functions as a commercial services and partnership platform, using a structured board-led vetting process to identify vendors that can improve hospital efficiency, financial performance, and care quality. Its offerings have included partnerships in areas such as interventional analytics, utilization management, staffing, performance improvement, energy solutions, and workforce safety. For a biotech analyst, this is best categorized as a healthcare services and market-access/channel organization serving provider systems, not a therapeutic product company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on THA Innovative Solutions.